Close
Back to RARE Stock Lookup

Ultragenyx Pharma (RARE) – Major News

Feb 15, 2024 04:05 PM Ultragenyx Pharma (RARE) Tops Q4 EPS by 18c
Nov 2, 2023 05:03 PM Ultragenyx Pharma (RARE) Misses Q3 EPS by 16c
Aug 3, 2023 04:53 PM Ultragenyx Pharma (RARE) Misses Q2 EPS by 16c, beats revenue
Feb 16, 2023 04:14 PM Ultragenyx Pharma (RARE) Misses Q4 EPS by 2c
Jul 28, 2022 04:42 PM Ultragenyx Pharma (RARE) Misses Q2 EPS by 51c; Reaffirms Product Revenue Guidance
May 5, 2022 05:33 PM Ultragenyx Pharma (RARE) Misses Q1 EPS by 43c
Feb 10, 2022 04:30 PM Ultragenyx Pharma (RARE) Misses Q4 EPS by 45c
Nov 2, 2021 05:11 PM Ultragenyx Pharma (RARE) Tops Q3 EPS by 33c
Aug 2, 2021 04:31 PM Ultragenyx Pharma (RARE) Misses Q2 EPS by 45c, Revenues Beat
May 4, 2021 04:02 PM Ultragenyx Pharma (RARE) Misses Q1 EPS by 79c, Revenues Beat
Feb 11, 2021 04:45 PM Ultragenyx Pharma (RARE) Reports Q4 Loss of $0.37 on Revenues of $91.54M
Oct 27, 2020 04:45 PM Ultragenyx Pharma (RARE) Tops Q3 EPS by 14c, Revenues Beat
Jul 30, 2020 05:14 PM Ultragenyx Pharma (RARE) Tops Q2 EPS by $1.95, Revenue Beat; Offers FY20 Crysvita Outlook
May 6, 2020 05:54 PM Ultragenyx Pharma (RARE) Misses Q1 EPS by 36c
Feb 13, 2020 04:04 PM Ultragenyx Pharma (RARE) Tops Q4 EPS by 3c, Revenues Beat
Nov 5, 2019 04:53 PM Ultragenyx Pharma (RARE) Misses Q3 EPS by 28c
Aug 1, 2019 05:39 PM Ultragenyx Pharma (RARE) Misses Q2 EPS by 2c, Revenues Beat
May 6, 2019 05:03 PM Ultragenyx Pharma (RARE) Misses Q1 EPS by 8c
Feb 19, 2019 04:05 PM Ultragenyx Pharma (RARE) Tops Q4 EPS by 6c, Revenues Beat
Nov 5, 2018 04:41 PM Ultragenyx Pharma (RARE) Tops Q3 EPS by 22c, Revenues Beat
Oct 26, 2018 08:01 AM Ultragenyx Pharma (RARE) phase 3 study of UX007 in patients with Glut1 DS did not achieve its primary endpoint
Aug 2, 2018 05:06 PM Ultragenyx Pharma (RARE) Posts Smaller-than-Expected Q2 Loss
May 7, 2018 04:20 PM Ultragenyx Pharma (RARE) Reports Q1 EPS of $0.62
Apr 17, 2018 01:29 PM Ultragenyx Pharma (RARE) Confirms FDA Approval of Crysvita for X–Linked Hypophosphatemia
Feb 20, 2018 04:12 PM Ultragenyx Pharma (RARE) Tops Q4 EPS by 10c
Nov 2, 2017 05:02 PM Ultragenyx Pharma (RARE) Misses Q3 EPS by 1c
Oct 10, 2017 08:32 AM Ultragenyx Pharma (RARE) Says FDA Accepts Burosumab BLA; Sets 04/17/18 PDUFA Date
Sep 18, 2017 08:36 AM Ultragenyx Pharma (RARE) Offers to Acqurie Dimension Therapeutics (DMTX) for $5.50/Share
Aug 22, 2017 04:06 PM Ultragenyx Pharma (RARE) Phase 3 Study of Ace-ER in GNE Myopathy Doesn't Achieve Primary Endpoint
Jul 27, 2017 04:45 PM Ultragenyx Pharma (RARE) Tops Q2 EPS by 1c
May 4, 2017 04:46 PM Ultragenyx Pharma (RARE) Tops Q1 EPS by 8c
Apr 18, 2017 04:05 PM Ultragenyx (RARE), Kyowa Hakko Kirin and Kyowa Kirin Announce Positive 24-Week Data from Adult Phase 3 Study of Burosumab
Mar 22, 2017 04:08 PM UPDATE: Ultragenyx (RARE) Phase 2 UX007 Study Fails to Meet Primary Endpoint
Feb 16, 2017 04:13 PM Ultragenyx Pharma (RARE) Misses Q4 EPS by 3c
Nov 7, 2016 04:36 PM Ultragenyx Pharma (RARE) Misses Q3 EPS by 11c
Aug 8, 2016 04:32 PM Ultragenyx Pharma (RARE) Misses Q2 EPS by 2c
May 9, 2016 05:22 PM Ultragenyx Pharma (RARE) Misses Q1 EPS by 6c
Feb 25, 2016 04:27 PM Ultragenyx Pharma (RARE) Misses Q4 EPS by 28c
Nov 9, 2015 04:23 PM Ultragenyx Pharma (RARE) Misses Q3 EPS by 16c
Aug 13, 2015 04:36 PM Ultragenyx Pharma (RARE) Misses Q2 EPS by 20c
Mar 25, 2015 04:06 PM Ultragenyx Pharma (RARE) Tops Q4 EPS by 1c
Nov 10, 2014 09:03 AM Ultragenyx Pharmaceutical (RARE) Misses Q3 EPS by 4c
Aug 11, 2014 09:02 AM Ultragenyx Pharmaceutical Inc. (RARE) Misses Q2 EPS by 3c
May 12, 2014 09:09 AM Ultragenyx Pharmaceutical Inc. (RARE) Posts Q1 Loss of 85c/Share
Jan 31, 2014 10:25 AM Ultragenyx Pharmaceutical (RARE) IPO More than Doubles

Back to RARE Stock Lookup